Intraoperative Radiation Therapy Market worth $68 million by 2024

The rising incidence of cancer, technological advancements such as the introduction of mobile IORT system, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market.

Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players.The Electron IORT segment to account for the largest share of the intraoperative radiation therapy market, by method, in 2019Download PDF Brochure@https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=245000083Based on method, the intraoperative radiation therapy market is segmented into electron IORT and intraoperative brachytherapy.

The electron IORT segment is expected to account for the largest share of the intraoperative radiation therapy market in 2019.

The large share of this segment can be attributed to its advantages such as better depth dose distribution, low treatment time, and optimal dose homogeneity as compared to HDR-IORT or kV IORT.The other cancers segment, by application, is to register the highest CAGR in the intraoperative radiation therapy market during the forecast periodBased on application, the intraoperative radiation therapy market is segmented into breast cancer, brain tumor, gastrointestinal cancer, head & neck cancer, and other cancers.

The other cancer application segment includes penile cancer, lung cancer, childhood cancer, colorectal cancer, endometrial & cervical cancer, and prostate cancer.

This segment is expected to grow at the fastest CAGR owing to growing research activities in new application areas of the IORT market.North America to dominate the intraoperative radiation therapy market during the forecast periodRead More@https://www.marketsandmarkets.com/PressReleases/intraoperative-radiation-therapy.aspThe intraoperative radiation therapy market is segmented into four regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World.

COVID-19 Impact Analysis on Intraoperative Radiation Therapy Market report published by Value Market Research provides a detailed market analysis comprising market size, share, value, growth and trends for the period 2020-2027.

Moreover, this market report also covers regional and country markets in detail.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.

The major players in the intraoperative radiation therapy market include Carl Zeiss AG, Ariane Medical Systems Ltd, Eckert & Ziegler, Elekta AB, GMV, Elekta AB (pub), iCAD Inc. , Xoft, IntraOp Medical, Inc., Sordina Iort Technologies, Varian Medical Systems, Inc.

This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Intraoperative Radiation Therapy Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/intraoperative-radiation-therapy-market/download-sampleMarket DynamicsThe growing prevalence of cancer and advantages offered by intraoperative radiation therapy is the key driver for the growth of this market.

IORT has several advantages over conventional radiotherapy like high precision, limited treatment time, etc.

Some factors like risk of radiation exposure, unavailability of trained personnel, etc may restraint the growth of the IORT market.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis.

The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

This study involved the extensive use of both primary and secondary sources.Major Growth Drivers:The rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market.Expected Revenue Growth:[159 Pages Report] The global intraoperative radiation therapy market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period.COVID-19 Impact on the global Intraoperative radiation therapy marketThe intraoperative radiation therapy market was significantly impacted by the COVID-19 pandemic.

Various screening, diagnostic, and surgical procedures were restricted or postponed at hospitals and cancer treatment centers, which resulted in disruptions in the cancer diagnosis as well as treatment market.

The pandemic also impacted the availability of healthcare resources.

Major regulatory authorities across the globe, such as the CDC, WHO, MHRA, TGA, and EMA, have identified cancer patients at a greater risk of contracting coronavirus disease than healthy adults.Browse in-depth TOC on “Intraoperative Radiation Therapy Market”77 – Tables33 – Figures159 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=245000083Growing global prevalence of cancerThe IORT procedure is associated with various advantages such as targeted radiation, limited treatment time, high precision and radiation control, and minimal radiation exposure of normal tissue.

This is especially true for breast cancer, as this mode offers women a choice of breast-sparing treatment (lumpectomy).